Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Completed 2Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Congenital Abnormalities 1

Interventions

zanubrutinib 1osimertinib 1Vincristine 1Trastuzumab 1Rituximab 1Quality of Life 1Prednisone 1Nutritional Status 1Microscopy, Confocal 1Interviews as Topic 1Heparin 1Exercise 1Erlotinib Hydrochloride 1Epirubicin 1Enoxaparin 1Docetaxel 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × OTHER_GOV × Prednisone × Clear all
NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Suspended
59 enrolled
Lymphoid

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡